<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>G. Mountzios | Prof. Nikolaos Korfiatis</title><link>https://nkorf.github.io/authors/g.-mountzios/</link><atom:link href="https://nkorf.github.io/authors/g.-mountzios/index.xml" rel="self" type="application/rss+xml"/><description>G. Mountzios</description><generator>HugoBlox Kit (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Wed, 01 Jan 2025 00:00:00 +0000</lastBuildDate><item><title>Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study</title><link>https://nkorf.github.io/publications/linardou2025ejc/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/linardou2025ejc/</guid><description/></item><item><title>Final outcome, immunophenotypic and biomarker analysis of intercalated avelumab plus platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (PAVE)</title><link>https://nkorf.github.io/publications/mountzios2024esmoopen/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/mountzios2024esmoopen/</guid><description/></item></channel></rss>